Galactorrhea Probably Related with Switching from Osmotic-release Oral System Methylphenidate (MPH) to Modified-release MPH: An Adolescent Case
Clinical Psychopharmacology and Neuroscience
;
: 282-284, 2017.
Article
in English
| WPRIM
| ID: wpr-152977
ABSTRACT
Galactorrhea, as an adverse effect of psychotropic medications, usually develops due to high dose of antipsychotics. Selective serotonin reuptake inhibitors (SSRIs) have also been reported to be related to galactorrhea. To the best of our knowledge, no previous study reported galactorrhea with methylphenidate (MPH) use. Hereby, we report a case of an adolescent girl who developed galactorrhea after increasing his modifed-release oral MPH to 50 mg/day while under treatment of sertraline and very low dose haloperidol.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Antipsychotic Agents
/
Selective Serotonin Reuptake Inhibitors
/
Sertraline
/
Galactorrhea
/
Haloperidol
/
Methylphenidate
Limits:
Adolescent
/
Female
/
Humans
/
Pregnancy
Language:
English
Journal:
Clinical Psychopharmacology and Neuroscience
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS